Day: April 10, 2018

Aestus receives $244.

Aestus receives $244,000 grant from QTDP program Aestus Therapeutics Today, Inc. Announced that it has been awarded a $244,000 grant from the U.S. Government’s Qualifying Therapeutic Discovery Task plan. The grant, awarded for the task, Treating neuropathic pain by way of novel mechanisms, will help to fund clinical trials of Aestus’s novel, first-in-class treatment for chronic neuropathic discomfort. PHN is defined as persistent pain following an outbreak of herpes zoster commonly, or shingles. Based on the National Institutes of Wellness , more than one million new situations of shingles are reported each full yr in the United States, many of which will lead to PHN. Read More